Dewhurst Martin William bought TTRX
January 7, 2026 · Form 4 insider transaction
Dewhurst Martin William bought 21,882 shares of Turn Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 28 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,882
Price
$0.00
Total value
N/A
InsiderDewhurst Martin William
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateFebruary 4, 2026
Shares owned after21,882
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2025 Omnibus Incentive Plan. The 21,882 RSUs included in Column 5 of Table I vest in full on January 7, 2027, subject to the reporting person's continuous service to the Issuer.